What is NDC 51759-348?

51759-348 is the product NDC for Weltruza (olanzapine) kit, listed with the FDA by Teva Pharmaceuticals USA, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Teva Pharmaceuticals USA, Inc., NDC labeler code 51759. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Weltruza?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Weltruza NDC 51759-348 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)51759-348Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51759-0348Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51759-348-50	5175903485051759034850	1 KIT in 1 CARTON (51759-348-50) * 1.2 mL in 1 VIAL (51759-354-50) * 1.3 mL in 1 SYRINGE (51759-357-10)Marketed from Nov 2, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Weltruza
Generic name (nonproprietary): olanzapine
Dosage form: Kit
Route: Subcutaneous
Labeler: Teva Pharmaceuticals USA, Inc.NDC labeler code 51759
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 219007
Marketing start: Nov 2, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 51759-348_1c998762-8d30-4afd-b0d5-282bcaaefb8dSPL ID 1c998762-8d30-4afd-b0d5-282bcaaefb8dSPL set ID a23e99c7-fb76-46d2-95af-e03d5a4d1f2c

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N451759034850 followed by a unit qualifier and the quantity

Package 51759-0348-50. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 26, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

WELTRUZA is indicated for the treatment of schizophrenia in adults. WELTRUZA is a long-acting atypical antipsychotic for subcutaneous injection indicated for the treatment of schizophrenia in adults. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51759-348

What is NDC 51759-348?: 51759-348 is the product NDC for Weltruza (olanzapine) kit, listed with the FDA by Teva Pharmaceuticals USA, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Weltruza (Olanzapine).
Who is the labeler?: Teva Pharmaceuticals USA, Inc., NDC labeler code 51759. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Weltruza?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under NDA 219007

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 219007
Product	Strength	Form · route	Labeler	Product NDC
Weltruzaolanzapine	—	KitSubcutaneous	Teva Pharmaceuticals USA, Inc.	51759-349
Weltruzaolanzapine	—	KitSubcutaneous	Teva Pharmaceuticals USA, Inc.	51759-347

Weltruza (Olanzapine) NDC 51759-348